As of November 2024, KalVista Pharmaceuticals has a market cap of $369.43M. This makes KalVista Pharmaceuticals the world's 13351th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $534.97M | 26.37% |
2023 | $423.34M | 81.21% |
2022 | $233.62M | -48.90% |
2021 | $457.21M | -30.33% |
2020 | $656.27M | 6.63% |
2019 | $615.49M | -9.82% |
2018 | $682.53M | 102.56% |
2017 | $336.95M | 37.91% |
2016 | $244.33M | -86.05% |
2015 | $1.75B | - |